Harrow Announces Availability of VEVYE® (Cyclosporine Ophthalmic Solution) 0.1%, the First and Only Cyclosporine-Based Product Indicated for Treating Both Signs and Symptoms of Dry Eye Disease
Stock Information for Eton Pharmaceuticals Inc.
Loading
Please wait while we load your information from QuoteMedia.